Brighter Side of News
HomeGood NewsDiscoveriesInnovationsGlobal GoodHealthGreen ImpactSpaceAICelebritiesGNISubscribe

Nasal Spray

Common allergy nasal spray reduces risk of COVID-19 infection by 66%

In a recent clinical trial, adults who used azelastine nasal spray were less likely to catch COVID-19 than those who used a look-alike placebo.

Joseph Shavit
The first needle-free flu shot, delivered right to your doorJoseph Shavit
Oxytocin nasal spray shows promise for treating alcoholism and obesityJoseph Shavit
Groundbreaking antibody nasal spray stops flu virusesRebecca Shavit
New nighttime nasal spray significantly alleviates sleep apneaJoseph Shavit
Revolutionary nasal spray transforms traumatic brain injury treatmentRebecca Shavit
Nasal spray drug could revolutionize Alzheimer’s treatmentJoshua Shavit
Breakthrough nasal spray can significantly improve cognitive performanceJoseph Shavit
Nasal spray alternative to the EpiPen is a life changer for people with allergiesRebecca Shavit
Lifechanging nasal spray can improve cognitive performanceJoshua Shavit
Breakthrough nasal spray reduces sleep apnea severity by 70%Joseph Shavit
Breakthrough nasal vaccine stops COVID-19 transmission coldJoshua Shavit
Lifesaving nasal spray targets and eliminates proteins that cause Alzheimer’sJoshua Shavit
Game-changing nasal spray slashes sleep apnea severity by 70%Joseph Shavit
Breakthrough nasal spray safely treats recurrent heart issuesJoshua Shavit
First-ever nasal spray protects against all COVID variantsJoseph Shavit
New nasal spray protects against all COVID variantsJoseph Shavit
Brighter Side of News
  • Explore
  • About Us
  • News Feed
  • Sitemap
  • Editorial Guidelines
  • Legal
  • Privacy
  • Terms
  • Read More
  • Newsletter Sign-up
  • Flipboard